225 related articles for article (PubMed ID: 36631830)
1. Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
Engel S; Halcour J; Ellwardt E; Uphaus T; Steffen F; Zipp F; Bittner S; Luessi F
Fluids Barriers CNS; 2023 Jan; 20(1):3. PubMed ID: 36631830
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
Knoche T; Gaus V; Haffner P; Kowski A
Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
[TBL] [Abstract][Full Text] [Related]
4. Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.
Jeppsson A; Sandelius Å; Zettergren A; Kern S; Skoog I; Blennow K; Zetterberg H; Wikkelsø C; Hellström P; Tullberg M
Fluids Barriers CNS; 2023 Jul; 20(1):54. PubMed ID: 37415175
[TBL] [Abstract][Full Text] [Related]
5. Low cerebrospinal fluid protein in prepubertal children with idiopathic intracranial hypertension.
Margeta MA; Buckley EG; El-Dairi MA
J AAPOS; 2015 Apr; 19(2):135-9. PubMed ID: 25828820
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model.
Yeo T; Bayuangga H; Augusto-Oliveira M; Sealey M; Claridge TDW; Tanner R; Leppert D; Palace J; Kuhle J; Probert F; Anthony DC
J Neuroinflammation; 2022 Oct; 19(1):252. PubMed ID: 36210459
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
[TBL] [Abstract][Full Text] [Related]
8. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
[TBL] [Abstract][Full Text] [Related]
10. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.
Körtvelyessy P; Kuhle J; Düzel E; Vielhaber S; Schmidt C; Heinius A; Leypoldt F; Schraven B; Reinhold D; Leppert D; Goihl A
Ann Clin Transl Neurol; 2020 Nov; 7(11):2213-2220. PubMed ID: 33030817
[TBL] [Abstract][Full Text] [Related]
11. The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis.
Adams A; Tilden W; Bestwick J; Holden D; Bianchi L; Smets I; Giovannoni G; Gnanapavan S
Eur J Neurol; 2022 Sep; 29(9):2754-2760. PubMed ID: 35615966
[TBL] [Abstract][Full Text] [Related]
12. The Pre-Lumbar puncture Intracranial Hypertension Scale (PLIHS): A practical scale to identify subjects with normal cerebrospinal fluid pressure in the management of idiopathic intracranial hypertension.
Raggi A; Bianchi Marzoli S; Ciasca P; Cammarata G; Melzi L; Chiapparini L; Erbetta A; Ciceri E; Faragò G; Gioppo A; Usai S; D'Amico D
J Neurol Sci; 2021 Oct; 429():118058. PubMed ID: 34461550
[TBL] [Abstract][Full Text] [Related]
13. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension.
Warner JE; Larson AJ; Bhosale P; Digre KB; Henley C; Alder SC; Katz BJ; Bernstein PS
J Neuroophthalmol; 2007 Dec; 27(4):258-62. PubMed ID: 18090557
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid total protein in idiopathic intracranial hypertension.
Berezovsky DE; Bruce BB; Vasseneix C; Peragallo JH; Newman NJ; Biousse V
J Neurol Sci; 2017 Oct; 381():226-229. PubMed ID: 28991687
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
J Neuroinflammation; 2018 Jul; 15(1):209. PubMed ID: 30021640
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
[TBL] [Abstract][Full Text] [Related]
17. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay.
Ulndreaj A; Sohaei D; Thebault S; Pons-Belda OD; Fernandez-Uriarte A; Campbell C; Cheo D; Stengelin M; Sigal G; Freedman MS; Scarisbrick IA; Prassas I; Diamandis EP
Diagnosis (Berl); 2023 Aug; 10(3):275-280. PubMed ID: 36788117
[TBL] [Abstract][Full Text] [Related]
19. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
Mult Scler Relat Disord; 2024 Apr; 87():105644. PubMed ID: 38701697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]